We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Drug Prevents Liver Scarring in People With HIV

News   Oct 14, 2019 | Original story from NIH

 
Drug Prevents Liver Scarring in People With HIV

A microscopic image of liver tissue affected by non-alcoholic fatty liver disease (NAFLD). The large and small white spots are excess fat droplets filling liver cells (hepatocytes). Credit: Dr. David Kleiner, NCI

 
 
 

RELATED ARTICLES

Promising Results From Experimental HIV Vaccine

News

An experimental HIV vaccine has reached an important milestone by eliciting antibodies that can neutralize a wide variety of HIV strains.

READ MORE

Looming Threat From Eastern Equine Encephalitis Virus

News

Although eastern equine encephalitis, a mosquito-borne illness, has existed for centuries, 2019 has been a particularly deadly year for the disease in the US and strategies to address this threat are urgently required.

READ MORE

Safety and Efficacy Results From CRISPR/Cas9 Human Clinical Trials Are Positive

News

CRISPR Therapeutics and Vertex Pharmaceuticals have announced their interim safety and efficacy results from the CTX001 CRISPR/Cas9 gene-editing human clinical trials - and they're promising.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE